11 news items
Investigational Acasunlimab (DuoBody® -PD-L1x4-1BB) in Combination with Pembrolizumab Demonstrates Meaningful Clinical Activity in Phase 2 Trial in Patients with Previously Treated Metastatic Non-small Cell Lung Cancer (mNSCLC)
BNTX
GMAB
1 Jun 24
biotechnology company with a core purpose of guiding its unstoppable team to strive toward improving the lives of patients with innovative
Investigational Acasunlimab (DuoBody® -PD-L1x4-1BB) in Combination with Pembrolizumab Demonstrates Meaningful Clinical Activity in Phase 2 Trial in Patients with Previously Treated Metastatic Non-small Cell Lung Cancer (mNSCLC)
BNTX
GMAB
1 Jun 24
improving the lives of patients with innovative and differentiated antibody therapeutics. For 25 years, its passionate, innovative and collaborative team
Genmab to Showcase Data in Various Patient Populations to be Presented at the American Society of Clinical Oncology (ASCO) Annual Meeting
GMAB
23 May 24
to strive toward improving the lives of patients with innovative and differentiated antibody therapeutics. For 25 years, its passionate, innovative
Genmab Completes Acquisition of ProfoundBio
GMAB
21 May 24
and continue to work towards our goal of transforming the lives of patients with innovative antibody medicines
Genmab Completes Acquisition of ProfoundBio
GMAB
21 May 24
of transforming the lives of patients with innovative antibody medicines." The acquisition gives Genmab worldwide rights to ProfoundBio's
fzyhiti3kfqlx9ub079
GMAB
14 May 24
improving the lives of patients through innovative and differentiated antibody therapeutics. For 25 years, its passionate, innovative
njt11
GMAB
PFE
29 Apr 24
towards improving the lives of patients through innovative and differentiated antibody therapeutics. For 25 years, its passionate, innovative
t0uib0o510pmc846shcjfvbkt kb9d68h5l6spbyanwyyggmqisxgj
GMAB
PFE
29 Apr 24
unstoppable team to strive towards improving the lives of patients through innovative and differentiated antibody therapeutics. For 25 years, its passionate
5lt5as4v142k9dujfwbt xyd
GMAB
PFE
29 Apr 24
unstoppable team to strive towards improving the lives of patients through innovative and differentiated antibody therapeutics. For 25 years, its
0e18xqidk6q8fek0ga0f8o2ublroc54796erau4ha3krl30jv6or2b47p
AVBP
GMAB
LLY
8 Apr 24
for $1.8 billion
The deal is the fourth acquisition of a China-related innovative drugmaker by a foreign company in the last four months
a0ag424m3n1p5cby
GMAB
3 Apr 24
2030 vision, to impact the lives of patients through innovative antibody medicines," said Jan van de Winkel, Ph.D., President and Chief Executive
- Prev
- 1
- Next